The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
(ADP-ribose)n participates in DNA excision repair
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly (ADP-Ribose) and ADP-Ribosylation of Proteins
Hayaishi, O., & Veda, K. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.000523 · Cited by 585
Poly ADP-ribose and ADP-ribosylation of proteins
Hayaishi, O. (1976) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(76)90255-3 · Cited by 572
Poly(ADP-ribose) levels in carcinogen-treated cells
Juarez-Salinas, H., Sims, J. L., & Jacobson, M. K. (1979) · Nature · doi:10.1038/282740a0 · Cited by 348
Poly(ADP-ribose) and ADP-ribosylation of proteins
Hilz, H., & Stone, P. (1976) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0027686 · Cited by 286
SKIDMORE, C. J., DAVIES, M. I., GOODWIN, P. M., HALLDORSSON, H., LEWIS, P. J., SHALL, S., & ZIA'EE, A. (1979) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1979.tb04225.x · Cited by 278
Self-citationEvidence for adenosine diphosphate ribosylation of Ca2+, Mg2+-dependent endonuclease.
Yoshihara, K., Tanigawa, Y., Burzio, L., & KOIDE, S. S. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.1.289 · Cited by 165
Defective thymine dimer excision by cell-free extracts of xeroderma pigmentosum cells.
Mortelmans, K., Friedberg, E. C., Slor, H., Thomas, G., & Cleaver, J. E. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2757 · Cited by 164
Specific inhibition of poly adpribose polymerase by thymidine and nicotinamide in HeLa cells
Preiss, J., SCHLAEGER, R., & Hilz, H. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80524-0 · Cited by 139
The inhibition of carbohydrate metabolism in ascites-tumour cells by ethyleneimines
Roitt, I. M. (1956) · Biochemical Journal · doi:10.1042/bj0630300 · Cited by 130
Clark, J. B., Ferris, G., & Pinder, S. (1971) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(71)90012-8 · Cited by 124
Cited by
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Murai, J., Huang, S.-Y. N., Das, B. B., Renaud, A., Zhang, Y., Doroshow, J. H., Ji, J., Takeda, S., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2753 · Cited by 2,192
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
DNA repair pathways as targets for cancer therapy
Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
State-of-the-art strategies for targeting the DNA damage response in cancer
Pilié, P. G., Tang, C., Mills, G. B., & Yap, T. A. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0114-z · Cited by 1,189
Role of poly(ADP-ribose) formation in DNA repair
Satoh, M. S., & Lindahl, T. (1992) · Nature · doi:10.1038/356356a0 · Cited by 1,174
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
Single-strand break repair and genetic disease
Caldecott, K. W. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2380 · Cited by 1,034
Helleday, T. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.001 · Cited by 856
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837
Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.
Wang, Z. Q., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M., & Wagner, E. F. (1995) · Genes & Development · doi:10.1101/gad.9.5.509 · Cited by 774
Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks
Lindahl, T., Satoh, M. S., Poirier, G. G., & Klungland, A. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89089-1 · Cited by 611
Menear, K. A., Adcock, C., Boulter, R., Cockcroft, X.-L., Copsey, L., Cranston, A., Dillon, K. J., Drzewiecki, J., Garman, S., Gomez, S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8001263 · Cited by 584
Poly(ADP-ribose) polymerase inhibition: past, present and future
Curtin, N. J., & Szabo, C. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0076-6 · Cited by 556
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
Pommier, Y., Pourquier, P., Fan, Y., & Strumberg, D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00129-8 · Cited by 551
Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?
Shall, S., & de Murcia, G. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00016-1 · Cited by 534
Self-citationYamamoto, H., Uchigata, Y., & Okamoto, H. (1981) · Nature · doi:10.1038/294284a0 · Cited by 526
Calcium‐activated DNA fragmentation kills immature thymocytes
McConkey, D. J., Hartzell, P., Nicotera, P., & Orrenius, S. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.7.2497041 · Cited by 520
Poly(ADP-ribosyl)ation of polynucleosomes causes relaxation of chromatin structure.
Poirier, G. G., de Murcia, G., Jongstra-Bilen, J., Niedergang, C., & Mandel, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3423 · Cited by 515
The macro domain is an ADP‐ribose binding module
Karras, G. I., Kustatscher, G., Buhecha, H. R., Allen, M. D., Pugieux, C., Sait, F., Bycroft, M., & Ladurner, A. G. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600664 · Cited by 505
Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
Herceg, Z., & Wang, Z.-Q. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00111-7 · Cited by 488
Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase.
Banasik, M., Komura, H., Shimoyama, M., & Ueda, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45983-2 · Cited by 476
Pettitt, S. J., Krastev, D. B., Brandsma, I., Dréan, A., Song, F., Aleksandrov, R., Harrell, M. I., Menon, M., Brough, R., Campbell, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03917-2 · Cited by 449
XRCC1 keeps DNA from getting stranded
Thompson, L. H., & West, M. G. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(99)00058-0 · Cited by 444
Dual Roles of PARP-1 Promote Cancer Growth and Progression
Schiewer, M. J., Goodwin, J. F., Han, S., Brenner, J. C., Augello, M. A., Dean, J. L., Liu, F., Planck, J. L., Ravindranathan, P., Chinnaiyan, A. M., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0120 · Cited by 442
PARP-1, a determinant of cell survival in response to DNA damage
Bouchard, V. J., Rouleau, M., & Poirier, G. G. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00083-3 · Cited by 388
Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
Seto, S., Carrera, C. J., Kubota, M., Wasson, D. B., & Carson, D. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111710 · Cited by 382
Benjamin, R. C., & Gill, D. M. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70490-6 · Cited by 376
Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond
Curtin, N. J., & Szabo, C. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.006 · Cited by 369
Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic
Ferraris, D. V. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100012m · Cited by 363
Activation of a Cytosolic ADP-ribosyltransferase by Nitric Oxide-generating Agents
Brüne, B., & Lapetina, E. G. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81808-7 · Cited by 360
Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
Scott, C. L., Swisher, E. M., & Kaufmann, S. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8848 · Cited by 355
NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
Cerutti, R., Pirinen, E., Lamperti, C., Marchet, S., Sauve, A. A., Li, W., Leoni, V., Schon, E. A., Dantzer, F., Auwerx, J., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.001 · Cited by 343
“…102±3 430±10*** 132±22 303±37 SCO2KOKI 477±47 106±4 318±26 70±10 93±21 SCO2KOKI – PARP-/- 452±65 132±11** 417±29** 107±5** 156±3** ** Student’s t test p 0.01 *** Student’s t test p 0.005 Table S3 related to Figure 2 and 3: Specific activities of citrate synthase (CS) and respiratory chain…”
InfluentialDNA strand breaks and ADP-ribosyl transferase activation during cell differentiation
Farzaneh, F., Zalin, R., Brill, D., & Shall, S. (1982) · Nature · doi:10.1038/300362a0 · Cited by 346
Self-citationThompson, L. H., Brookman, K. W., Dillehay, L. E., Carrano, A. V., Mazrimas, J. A., Mooney, C. L., & Minkler, J. L. (1982) · Mutation Research · doi:10.1016/0027-5107(82)90276-7 · Cited by 321
The role of PARP in DNA repair and its therapeutic exploitation
Javle, M., & Curtin, N. J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.382 · Cited by 320
Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1
Eustermann, S., Wu, W.-F., Langelier, M.-F., Yang, J.-C., Easton, L. E., Riccio, A. A., Pascal, J. M., & Neuhaus, D. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.032 · Cited by 318
Jones, P., Altamura, S., Boueres, J., Ferrigno, F., Fonsi, M., Giomini, C., Lamartina, S., Monteagudo, E., Ontoria, J. M., Orsale, M. V., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901188v · Cited by 316
Fisher, A. E. O., Hochegger, H., Takeda, S., & Caldecott, K. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02248-06 · Cited by 314
Overview of Base Excision Repair Biochemistry
Kim, Y.-J., & M. Wilson III, D. (2012) · Current Molecular Pharmacology · doi:10.2174/1874467211205010003 · Cited by 309
Fink, M. P. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70161-5 · Cited by 302
Grube, K., & Bürkle, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11759 · Cited by 301
DNA strand breaks, NAD metabolism, and programmed cell death
Carson, D. A., Seto, S., Wasson, D. B., & Carrera, C. J. (1986) · Experimental Cell Research · doi:10.1016/0014-4827(86)90028-5 · Cited by 301
Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
Murai, J., Feng, Y., Yu, G. K., Ru, Y., Tang, S.-W., Shen, Y., & Pommier, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12266 · Cited by 297
New functions of a long‐known molecule: Emerging roles of NAD in cellular signaling
Ziegler, M. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01187.x · Cited by 289
White, A. W., Almassy, R., Calvert, A. H., Curtin, N. J., Griffin, R. J., Hostomsky, Z., Maegley, K., Newell, D. R., Srinivasan, S., & Golding, B. T. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000950v · Cited by 288
Tankyrase-targeted therapeutics: expanding opportunities in the PARP family
Riffell, J. L., Lord, C. J., & Ashworth, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3868 · Cited by 285
Calcium-activated DNA Fragmentation in Rat Liver Nuclei
Jones, D. P., McConkey, D. J., Nicotera, P., & Orrenius, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83363-4 · Cited by 278
DNA Damage Response Genes and the Development of Cancer Metastasis
Broustas, C. G., & Lieberman, H. B. (2014) · Radiation Research · doi:10.1667/rr13515.1 · Cited by 275
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283
Oxidatively induced DNA damage and its repair in cancer
Dizdaroglu, M. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.11.002 · Cited by 254
Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes
Cantó, C., Sauve, A. A., & Bai, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.004 · Cited by 246
“The first function to be discovered for PARP-1 (and later PARP-2 and -3) was its involvement in DNA repair (Durkacz et al., 1980; Purnell and Whish, 1980).”
BackgroundTrapping Poly(ADP-Ribose) Polymerase
Shen, Y., Aoyagi-Scharber, M., & Wang, B. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.222448 · Cited by 230
Glycolysis: A multifaceted metabolic pathway and signaling hub
Kierans, S. J., & Taylor, C. T. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107906 · Cited by 198
Cisplatin Resistance Associated with PARP Hyperactivation
Michels, J., Vitale, I., Galluzzi, L., Adam, J., Olaussen, K. A., Kepp, O., Senovilla, L., Talhaoui, I., Guegan, J., Enot, D. P., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3000 · Cited by 176
Cheng, H., Zhang, Z., Borczuk, A., Powell, C. A., Balajee, A. S., Lieberman, H. B., & Halmos, B. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs393 · Cited by 99
Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors
Lim, J., & Tan, D. S. P. (2017) · Cancers · doi:10.3390/cancers9080109 · Cited by 52
Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future
Hu, M.-L., Pan, Y.-R., Yong, Y.-Y., Liu, Y., Yu, L., Qin, D.-L., Qiao, G., Law, B. Y.-K., Wu, J.-M., Zhou, X.-G., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102078 · Cited by 44
Lucock, M., Jones, P., Martin, C., Yates, Z., Veysey, M., Furst, J., & Beckett, E. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy013 · Cited by 17
Metadata
- Authors
- Durkacz, B. W., Omidiji, O., Gray, D. A., & Shall, S.
- Venue
- Nature
- Published
- 1980-02
- Volume
- 283
- Issue
- 5747
- Pages
- 593-596
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2077559325
- Cited by
- 1,121
- References
- 13
- FWCI
- 26.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.